Tumors grew more slowly and responded better to immunotherapy in mice that exercised compared with sedentary mice.
- Inpatient mammograms are a feasible approach to deliver preventive care to hospitalized women who may face significant barriers to completing the test in the outpatient setting
Andrew S. Hwang, MD, MPH
Attaining equitable health outcomes for all patients will require innovative solutions that lower the barriers to care by addressing patients’ psychosocial needs.
Massachusetts General Hospital
BOSTON — Completing cancer screening tests, such as mammograms, can be challenging for low-income people, who may face such challenges as lack of transportation or inability to take time off work. A team at Massachusetts General Hospital (MGH) explored the possibility of addressing preventive care needs when patients are admitted to the hospital.
The pilot study, published in the Annals of Family Medicine, examined the feasibility of performing mammograms in women insured by Medicaid or both Medicaid and Medicare (dual-eligible patients) while they were hospitalized. “We designed the study to reach the patients who face significant barriers to completing their mammograms in the outpatient setting,” says Andrew S. Hwang, MD, MPH, an internist at MGH and first author of the study. “National and local data show that Medicaid and dual-eligible patients have low rates of breast cancer screening. This targeted strategy has the potential to reduce disparities in cancer screening rates by addressing patients’ acute medical needs and their preventive care needs simultaneously.”
Hwang and his colleagues identified Medicaid and dual-eligible patients who were admitted to MGH’s General Medicine service and were overdue for mammograms. The women had primary care physicians affiliated with MGH who would be responsible for following up on abnormal mammogram results in collaboration with the MGH Breast Evaluation Team.
Of the 21 women who were identified as appropriate candidates for an inpatient mammogram, 17 women, who were an average age of 59, successfully completed the mammogram. The other four patients were discharged from the hospital before the mammograms could be coordinated. Of the 17 women who completed an inpatient mammogram, 35% had never had a mammogram and the other women were overdue for their mammograms by four years on average. All the mammograms were negative, except one, which was inconclusive, and additional imaging evaluation was recommended to rule out cancer. Completing a mammogram did not increase the patients’ hospital length of stay.
Hwang and his colleagues hope to build on the pilot study by offering inpatient mammograms to Medicaid and dual-eligible patients admitted to other areas of the hospital. They also envision potentially delivering additional preventive care services, such as fecal immunochemical tests for colorectal cancer screening, to low-income hospitalized men and women.
“The patients who participated in our pilot study faced significant psychosocial challenges to completing outpatient prevention tests,” says Hwang. “Attaining equitable health outcomes for all patients will require innovative solutions that lower the barriers to care by addressing patients’ psychosocial needs. In addition, as our health care system transitions from fee-for-service to value-based payment models, improving health outcomes among underserved patient populations will become increasingly important. Completing preventive screening tests, such as mammograms, during hospitalizations can be one way to help patients who might otherwise miss preventive care.”
Andrew Hwang, MD, MPH, is an assistant in Medicine at MGH and an instructor in Medicine at Harvard Medical School (HMS). Brian N. Dontchos, MD, is an instructor in Radiology at HMS. Karen Dyer is the operations manager of the Avon Breast Center at MGH. Jennifer Murray is the technical manager of the Avon Breast Center at MGH. Jennifer Searl Como, MS, is the program director for Population Health Quality Management at MGH. Daniel M. Horn, MD, is director of Population Health at MGH and an instructor in Medicine at HMS.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America’s Best Hospitals."
- Press Release
- Apr | 1 | 2021
New research reveals that when breast cancer cells spread to the brain, they must boost production of fatty acids, the building blocks of fat, in order to survive there.
- Press Release
- Mar | 2 | 2021
Experts offer guidance to reduce false positive tests and avoid unnecessary biopsies.
- Press Release
- Feb | 9 | 2021
Investigators at MIT and MGH have collaborated to develop a new AI model to predict a woman’s future risk of breast cancer based on her mammogram alone, and performed validation trials in patient populations in Europe and Asia.
- Press Release
- Feb | 12 | 2020
An increase in ribosomes, the protein-making machinery found in every living cell, increases their potential to form metastasis.